Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for type 2 diabetes management
Our domestic production pipeline ensures full chain-of-custody visibility, from raw API sourcing through final lyophilization and vial closure
Their effectiveness in sustained weight loss has made them a popular choice in the medical weight loss space
Labs are included in your plan at no extra cost, but are recommended, not required
How to Handle Holiday Side Effects Like a Pro Nausea Toolkit Common triggers: large meals, greasy foods, sugary desserts, alcohol, eating too late, dehydration
Getting clear, straightforward answers is a huge part of feeling in control